Hildegard Boss

540 total citations
28 papers, 416 citations indexed

About

Hildegard Boss is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Hildegard Boss has authored 28 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Hildegard Boss's work include Acute Ischemic Stroke Management (5 papers), Stroke Rehabilitation and Recovery (4 papers) and Sleep and related disorders (3 papers). Hildegard Boss is often cited by papers focused on Acute Ischemic Stroke Management (5 papers), Stroke Rehabilitation and Recovery (4 papers) and Sleep and related disorders (3 papers). Hildegard Boss collaborates with scholars based in Netherlands, United States and Germany. Hildegard Boss's co-authors include H. Timmerman, Geert Jan Sterk, Armin Hatzelmann, Renske M. van den Berg‐Vos, Sander M. Van Schaik, Henry C. Weinstein, Mirjam I. Geerlings, Wendy MJ Bosboom, R. Nave and Michèl A.A.P. Willemsen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Hildegard Boss

26 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hildegard Boss Netherlands 14 93 83 78 76 75 28 416
Jukka T. Salonen Finland 8 95 1.0× 14 0.2× 86 1.1× 106 1.4× 49 0.7× 9 467
Yunyun Zhang China 12 84 0.9× 46 0.6× 134 1.7× 35 0.5× 26 0.3× 44 412
Hannah L. Rosenberg United States 4 103 1.1× 20 0.2× 178 2.3× 34 0.4× 38 0.5× 6 646
Maxwell Elia United States 7 158 1.7× 147 1.8× 81 1.0× 52 0.7× 104 1.4× 13 671
Karl‐Peter Ittner Germany 12 46 0.5× 38 0.5× 50 0.6× 77 1.0× 49 0.7× 17 313
Fahimeh Hosseini Iran 7 41 0.4× 15 0.2× 90 1.2× 16 0.2× 14 0.2× 17 531
Naoyuki Fujimura Japan 11 49 0.5× 11 0.1× 73 0.9× 35 0.5× 75 1.0× 43 383
Can He China 12 100 1.1× 8 0.1× 117 1.5× 53 0.7× 72 1.0× 25 446
Amie J. Dirks‐Naylor United States 11 103 1.1× 6 0.1× 107 1.4× 54 0.7× 34 0.5× 23 412
Teresa Anna Cantisani Italy 10 25 0.3× 9 0.1× 28 0.4× 87 1.1× 17 0.2× 23 279

Countries citing papers authored by Hildegard Boss

Since Specialization
Citations

This map shows the geographic impact of Hildegard Boss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hildegard Boss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hildegard Boss more than expected).

Fields of papers citing papers by Hildegard Boss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hildegard Boss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hildegard Boss. The network helps show where Hildegard Boss may publish in the future.

Co-authorship network of co-authors of Hildegard Boss

This figure shows the co-authorship network connecting the top 25 collaborators of Hildegard Boss. A scholar is included among the top collaborators of Hildegard Boss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hildegard Boss. Hildegard Boss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metz, Juriaan R., et al.. (2024). Actigraphy‐based assessment of circadian rhythmicity and sleep in patients with Usher syndrome type 2a: A case–control study. Journal of Sleep Research. 34(4). e14456–e14456.
2.
Witteman, Ben, et al.. (2023). Effects of multidomain lifestyle interventions on cognitive decline and Alzheimer's disease prevention: A literature review and future recommendations. SHILAP Revista de lepidopterología. 4. 100166–100166. 6 indexed citations
3.
Boss, Hildegard, Gert Kwakkel, Erwin E. H. van Wegen, et al.. (2022). Effect of an exercise intervention on global cognition after transient ischemic attack or minor stroke: the MoveIT randomized controlled trial. BMC Neurology. 22(1). 289–289. 15 indexed citations
4.
5.
Boss, Hildegard, Sander M. Van Schaik, Henry C. Weinstein, et al.. (2017). Cardiorespiratory Fitness after Transient Ischemic Attack and Minor Ischemic Stroke: Baseline Data of the MoveIT Study. Journal of Stroke and Cerebrovascular Diseases. 26(5). 1114–1120. 16 indexed citations
6.
Horsmans, Yves, Oren Shibolet, Michelle Quinlan, et al.. (2017). Effects of Mild to Severe Hepatic Impairment on the Pharmacokinetics of Sonidegib: A Multicenter, Open-Label, Parallel-Group Study. Clinical Pharmacokinetics. 57(3). 345–354. 15 indexed citations
7.
Macarulla, Teresa, Josep Tabernero, Daniel H. Palmer, et al.. (2016). A phase Ib dose escalation, safety, and tolerability study of sonidegib in combination with gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma.. Journal of Clinical Oncology. 34(4_suppl). 371–371. 7 indexed citations
8.
Boss, Hildegard, et al.. (2015). Physical Activity and Vascular Events and Mortality in Patients with Vascular Disease. Medicine & Science in Sports & Exercise. 47(11). 2359–2365. 7 indexed citations
9.
Vries, Evelien E. de, Kees P. J. Braun, Hildegard Boss, et al.. (2015). Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome. Epilepsia. 57(2). e45–50. 37 indexed citations
10.
Boss, Hildegard, Sander M. Van Schaik, Erik Scherder, et al.. (2014). A randomised controlled trial of aerobic exercise after transient ischaemic attack or minor stroke to prevent cognitive decline: the MoveIT study protocol. BMJ Open. 4(12). e007065–e007065. 23 indexed citations
11.
Boss, Hildegard, et al.. (2014). Physical activity, structural brain changes and cognitive decline. The SMART-MR study. Atherosclerosis. 234(1). 47–53. 16 indexed citations
12.
Boss, Hildegard, Sander M. Van Schaik, Erik Scherder, et al.. (2014). Safety and feasibility of post-stroke care and exercise after minor ischemic stroke or transient ischemic attack: MotiveS & MoveIT. Neurorehabilitation. 34(3). 401–407. 26 indexed citations
13.
Kress, Hans G., et al.. (2010). Transdermal fentanyl matrix patches Matrifen® and Durogesic® DTrans® are bioequivalent. European Journal of Pharmaceutics and Biopharmaceutics. 75(2). 225–231. 15 indexed citations
14.
Nave, R., Henrik Watz, Hans Hoffmann, Hildegard Boss, & H Magnussen. (2010). Deposition and metabolism of inhaled ciclesonide in the human lung. European Respiratory Journal. 36(5). 1113–1119. 19 indexed citations
15.
16.
Boss, Hildegard, Armin Hatzelmann, Geert Jan Sterk, et al.. (2002). Novel Selective Phosphodiesterase (PDE4) Inhibitors. 4. Resolution, Absolute Configuration, and PDE4 Inhibitory Activity of cis-Tetra- and cis-Hexahydrophthalazinones. Journal of Medicinal Chemistry. 45(12). 2526–2533. 38 indexed citations
17.
Boss, Hildegard, et al.. (2002). Novel Selective PDE4 Inhibitors. 3. In Vivo Antiinflammatory Activity of a New Series of N-Substituted cis-Tetra- and cis-Hexahydrophthalazinones. Journal of Medicinal Chemistry. 45(12). 2520–2525. 13 indexed citations
18.
Boss, Hildegard, et al.. (1994). Dexniguldipine-HCl modulates the MDR1 mediated drug resistance in a nude mouse xenograft model. Anti-Cancer Drugs. 5. 29–29. 1 indexed citations
19.
Boss, Hildegard, et al.. (1990). Central and Peripheral Hypotensive Activity of Urapidil and its M1 and M2 Metabolites in the Cat. Drugs. 40(Supplement 4). 34–37. 1 indexed citations
20.
Janke, Wilhelm & Hildegard Boss. (1961). [Experimental studies on the psychic effects of a new psychotonic drug].. PubMed. 11. 783–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jukka T. Salonen Breakdown of academic impact, for papers by Yunyun Zhang Breakdown of academic impact, for papers by Hannah L. Rosenberg Breakdown of academic impact, for papers by Maxwell Elia Breakdown of academic impact, for papers by Karl‐Peter Ittner Breakdown of academic impact, for papers by Fahimeh Hosseini Breakdown of academic impact, for papers by Naoyuki Fujimura Breakdown of academic impact, for papers by Can He Breakdown of academic impact, for papers by Amie J. Dirks‐Naylor Breakdown of academic impact, for papers by Teresa Anna Cantisani
Rankless by CCL
2026